Surrogate endpoint
A measure such as amyloid plaque reduction or fluid biomarkers integrated into trial designs to enable earlier readouts.
Source: Trends in Neuroscience Drug Discovery and Development (L.E.K. Consulting) · p.7
Have a question about Surrogate endpoint? Ask the AI, answers cite the source.